Efficacy and safety of TACE combined with anlotinib compared with TACE alone among patients with intermediate or advanced hepatocellular carcinoma (HCC): A randomized, controlled, phase II clinical study.

被引：0
|
作者：
Zeng, Hui
Shao, Guoliang
机构：
[1] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med, Dept Intervent Radiol,Canc Hosp, Hangzhou, Peoples R China
[2] Zhejing Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of TACE combined with traditional Chinese medicine versus TACE alone in hepatocellular carcinoma: bayesian network meta-analysis and pharmacological mechanisms study
    Chen, Li
    Zhu, Xiu-Ling
    Lin, Jie
    Li, Dong-Liang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Efficacy and safety of anlotinib combined with transarterial chemoembolization versus transarterial chemoembolization alone in patients with unresectable hepatocellular carcinoma: A retrospective study.
    Guo, Wenbo
    Chen, Song
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] TACE combined with apatinib in patients with intermediate and advanced hepatocellular carcionma: A prospective, multi-center, randomized clinical trial
    Liang, B.
    Ma, Y.
    Huang, M.
    Zhang, X.
    Yu, L.
    Luo, Y.
    Liu, R.
    Zhou, S.
    Xu, G.
    Li, H-L.
    Liao, Z.
    Xiang, H.
    Lu, W.
    Xu, L.
    Zheng, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S1455 - S1455
  • [34] Efficacy and Safety of TACE Combined with a Tyrosine Kinase Inhibitor for the Treatment of TACE-Refractory Hepatocellular Carcinoma: A Retrospective Comparative Study
    Chen, Yu-Xing
    Zhang, Jin-Xing
    Zhou, Chun-Gao
    Liu, Jin
    Liu, Sheng
    Shi, Hai-Bin
    Zu, Qing-Quan
    Cheng, Yuan
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 924 - 931
  • [35] Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)-Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective Study
    Ouyang, Tao
    Cao, Yanyan
    Chen, Lei
    Zheng, Chuansheng
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 45 (06) : 780 - 790
  • [36] Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)–Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective Study
    Tao Ouyang
    Yanyan Cao
    Lei Chen
    Chuansheng Zheng
    CardioVascular and Interventional Radiology, 2022, 45 : 780 - 790
  • [37] TACTICS: Final overall survival (OS) data from a randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients (pts) with hepatocellular carcinoma (HCC)
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Ikeda, Masafumi
    Torimura, Takuji
    Aikata, Hiroshi
    Izumi, Namiki
    Yamasaki, Takahiro
    Hino, Keisuke
    Kuzuya, Teiji
    Isoda, Norio
    Yasui, Kohichiroh
    Aino, Hajime
    Ido, Akio
    Kawabe, Naoto
    Nakao, Kazuhiko
    Wada, Yoshiyuki
    Yoshimura, Kenichi
    Okusaka, Takuji
    Furuse, Junji
    Arai, Yasuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [38] TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial
    Hai-Dong Zhu
    Xiao Li
    Jian-Song Ji
    Ming Huang
    Guo-Liang Shao
    Jian Lu
    Xu-Ya Zhao
    Hai-Liang Li
    Zheng-Qiang Yang
    Jian-Fei Tu
    Jin-Mei Zhou
    Chu-Hui Zeng
    Gao-Jun Teng
    European Radiology, 2022, 32 : 7335 - 7343
  • [39] TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial
    Zhu, Hai-Dong
    Li, Xiao
    Ji, Jian-Song
    Huang, Ming
    Shao, Guo-Liang
    Lu, Jian
    Zhao, Xu-Ya
    Li, Hai-Liang
    Yang, Zheng-Qiang
    Tu, Jian-Fei
    Zhou, Jin-Mei
    Zeng, Chu-Hui
    Teng, Gao-Jun
    EUROPEAN RADIOLOGY, 2022, 32 (11) : 7335 - 7343
  • [40] PHASE II TRIAL OF SORAFENIB COMBINED WITH DOXORUBICIN ELUTING BEAD-TRANSARTERIAL CHEMOEMBOLIZATION (DEB-TACE) FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): INTERIM SAFETY AND EFFICACY ANALYSIS
    Reyes, Diane K.
    Azad, Nilofer
    Kamel, Ihab R.
    Koteish, Ayman A.
    Hamilton, James P.
    Pawlik, Timothy M.
    Choti, Michael A.
    Geschwind, Jean-Francois H.
    HEPATOLOGY, 2009, 50 (06) : 6A - 7A
12345